Avelumab
Avelumab | |
---|---|
Term | Avelumab |
Short definition | avelumab (a-VEL-yoo-mab) drug that binds to the protein PD-L1 to help immune cells kill cancer cells better and is used to treat various types of cancer. Avelumab is used alone or with other medicines to treat certain types of advanced renal cell carcinoma (a type of kidney cancer), urothelial cancer (a type of cancer in the bladder or urinary tract), and Merkel cell carcinoma (a rare type of skin cancer). |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
avelumab - (pronounced) (a-VEL-yoo-mab) drug that binds to the protein PD-L1 to help immune cells kill cancer cells better and is used to treat various types of cancer. Avelumab is used alone or with other medicines to treat certain types of advanced renal cell carcinoma (a type of kidney cancer), urothelial cancer (a type of cancer in the bladder or urinary tract), and Merkel cell carcinoma (a rare type of skin cancer). It is also being studied in the treatment of other types of cancer. Avelumab can block PD-L1 and help the immune system kill cancer cells. It's a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called Bavencio
External links
- Medical encyclopedia article on Avelumab
- Wikipedia's article - Avelumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski